Medication Harm Reduction
Medication Harm Reduction is a clinical strategy within oncology pharmacotherapy that systematically identifies and mitigates adverse drug effects through the rational discontinuation or modification of nonessential, inappropriate, or harmful medications to optimize patient outcomes.
275
Publications
11.4K
Citations
1.2K
Authors
589
Institutions
Publications per year
2017–2026
156
Parents
275
Natasha K. Martin, Peter Vickerman, Jason Grebely et al. · Hepatology · 2013 · 502 citations · Full text
Charlotte van den Berg, Colette Smit, Giel van Brussel et al. · Addiction · 2007 · 315 citations · Full text
Public Health, Infectious Disease Control, Preventive Medicine +16
Psychoactive drugs and harm reduction: from faith to science.
Nick Heather, Alex Wodak, Ethan A. Nadelmann et al. · 1993 · 266 citations
1–5 of 275
1.2K
5
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 1.2K
589
Yale University
New Haven, United States
11 h-index
25 publications
1.1K citations

UNSW Sydney
Sydney, Australia
8 h-index
18 publications
2K citations

The University of Queensland
Brisbane, Australia
8 h-index
24 publications
504 citations
Harm Reduction Services
Sacramento, United States
8 h-index
13 publications
411 citations

University of British Columbia
Vancouver, Canada
8 h-index
14 publications
1K citations

University of Bristol
Bristol, United Kingdom
7 h-index
9 publications
1.4K citations
University of Pennsylvania
Philadelphia, United States
7 h-index
20 publications
1.1K citations
University of Washington
Seattle, United States
7 h-index
38 publications
1.3K citations
1–8 of 589
26 publications · 1K citations
17
h-index
HRJ · 19 publications · 823 citations
16
h-index
13 publications · 1.1K citations
13
h-index
Repository · 9 publications · 360 citations
9
h-index
7 publications · 237 citations
7
h-index
1–5